ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselCaris Life Sciences Switzerland Holdings GmbH
Caris Life Sciences Switzerland Holdings GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Caris Life Sciences Switzerland Holdings GmbH provides comprehensive molecular profiling, protein analysis and AI-based interpretation to deliver therapy-relevant information for patients, physicians and biopharma partners. Its offerings include tissue- and blood-based tests (for example MI Profile and Caris Assure), molecular tumor board services, and multimodal molecular and clinical data and analysis tools for research and clinical development.

AI-generated
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Caris Life Sciences Switzerland Holdings GmbH

Offering

Products & services

Industry:Research & DevelopmentMedical Laboratories
✓ Offered12
Comprehensive molecular tumor profiling
Comprehensive molecular tumor profiling for solid tumors, analysis of DNA, RNA and proteins from tissue using WES, WTS, IHC and AI-supported interpretation.
MI Cancer Seek
Simultaneous WES/WTS assay for solid tumors, analysis of 23,000+ genes from tissue, FDA-approved CDx indications, therapy- and biomarker-oriented.
Blood-based molecular diagnostics
Blood-based analyses for cancer profiling and early detection, including liquid biopsy, whole blood profiling and multi-cancer early detection.
Caris Detect
Multi-cancer early detection blood test, analysis of the entire genome from blood to detect cancer signals before symptom onset.
Caris Assure
Whole blood liquid biopsy, analysis of plasma and buffy coat for more comprehensive molecular profiling from a blood sample.
Caris ChromoSeq
Whole-genome sequencing assay for myeloid malignancies from blood or bone marrow for diagnosis, risk stratification and treatment decision-making.
Caris MI Clarity
AI-powered prognostic test for HR+/HER2- early-stage breast cancer, evaluation of digitized H&E whole-slide images and clinical information.
MI Profile
Comprehensive molecular profiling from tumor tissue, analysis of DNA, RNA and proteins with AI-predictive algorithms for treatment decisions.
MI Tumor Seek Hybrid
NGS-based tissue test that captures DNA and RNA in a single assay and provides AI signatures for diagnosis and therapy selection.
Caris Molecular Tumor Board
Molecular case discussion for physicians, support for interpreting profiling results, treatment decisions and clinical contextualization.
Clinical Trial Matching
Matching molecular findings with appropriate clinical trials to refer patients to biology-matched trials.
Biopharma Molecular Profiling
Molecular profiling for biopharma partners, including WES, WTS, protein analysis and whole-slide imaging to support research and development programs.
Trust & reputation

ranQ Trust Score of Caris Life Sciences Switzerland Holdings GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Caris Life Sciences Switzerland Holdings GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Caris Life Sciences Switzerland Holdings GmbH scores 80.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Caris Life Sciences Switzerland Holdings GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Caris Life Sciences Switzerland Holdings GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Caris Life Sciences Switzerland Holdings GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Caris Life Sciences Switzerland Holdings GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Caris Life Sciences Switzerland Holdings GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Caris Life Sciences Switzerland Holdings GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Caris Life Sciences Switzerland Holdings GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Sandgrubenstrasse 44
4058 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-272.189.713
Founded
2013 · 13 years
Last commercial register change
September 11, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GA
    Galvita AG
    Basel
    SA
    SpiroChem AG
    Basel
    AA
    ARTIDIS AG
    Basel
    LS
    Lantheus Switzerland GmbH
    Basel
    IF
    Institut für molekulare und klinische Ophthalmologie Basel
    Basel
    PA
    PharmaTrail AG
    Basel
    NA
    NOUSCOM AG
    Basel
    IA
    Indivi AG
    Basel